Series B funding round for Quell Therapeutics raising $160M in November 2021
Series B funding round for Quell Therapeutics raising $160M in November 2021
| Investor | Firm Type |
|---|
| Partner |
|---|
Jeito CapitalLEAD | Venture Capital | — |
FidelityLEAD | Venture Capital | — |
SV Life SciencesLEAD | Private | — |
| Venture Capital | — | |
| Government Office | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$204.6M
Top Valuation
-
Quell Therapeutics raised $160M in a Series B round.
The round was announced on 11/01/21.
The round was led by Fidelity Management & Research Company, Rachel Mears, Wayne Holman, Houman Ashrafian.